Company Overview and News

0
BHP soars as ASX sheds cautious sentiment

13h theage.com.au
The Australian sharemarket has rebounded from two days in the red, following a strong session for mining giant BHP Billiton.
BGCHY NCMGF WOPEF NCM BLT MS.PRE MS.PRF MS.PRG MS.PRA OGFGY OISHF BEPTF NWS MS OSH GJV OISHY NWSA BHPBF BGA WPL BCHEY WOPEY BPT TNE NCMGY MS.PRI BHP MS.PRK BBL BHP OGFGF BHPLF ORG

0
BHP soars as ASX sheds cautious sentiment

13h smh.com.au
The Australian sharemarket has rebounded from two days in the red, following a strong session for mining giant BHP Billiton.
BGCHY NCMGF WOPEF NCM BLT MS.PRE MS.PRF MS.PRG MS.PRA OGFGY OISHF BEPTF NWS MS OSH GJV OISHY NWSA BHPBF BGA WPL BCHEY WOPEY BPT TNE NCMGY MS.PRI BHP MS.PRK BBL BHP OGFGF BHPLF ORG

2
Commodity slide sends ASX investors to the exits

2018-07-17 theage.com.au
Investors remained cautious on the Australian sharemarket on Tuesday as shares fell for second session in a row, led lower by resource stocks.
WOPEF RIO BLT RIO BDREF OGFGY OISHF RTPPF ASLEF RTNTF OSH OISHY BHPBF BDR ARLRY WPL AHY WOPEY BHP RIO BBL BHP OGFGF BHPLF ORG

2
Commodity slide sends ASX investors to the exits

2018-07-17 smh.com.au
Investors remained cautious on the Australian sharemarket on Tuesday as shares fell for second session in a row, led lower by resource stocks.
WOPEF RIO BLT RIO BDREF OGFGY OISHF RTPPF ASLEF RTNTF OSH OISHY BHPBF BDR ARLRY WPL AHY WOPEY BHP RIO BBL BHP OGFGF BHPLF ORG

2
ASX advances on bank strength as CSL breaks $200

2018-07-12 theage.com.au
The Australian sharemarket has closed higher despite an overnight commodity plunge that saw Brent crude prices record their biggest fall in two years.
WOPEF RIO BLT RIO OGFGY BEPTF RTPPF RTNTF TWE TSRYY BHPBF WTCHF WPL BCHEY WOPEY BPT TSRYF TNE BHP RIO BBL BHP OGFGF BHPLF ORG

2
ASX advances on bank strength as CSL breaks $200

2018-07-12 smh.com.au
The Australian sharemarket has closed higher despite an overnight commodity plunge that saw Brent crude prices record their biggest fall in two years.
WOPEF RIO BLT RIO OGFGY BEPTF RTPPF RTNTF TWE TSRYY BHPBF WTCHF WPL BCHEY WOPEY BPT TSRYF TNE BHP RIO BBL BHP OGFGF BHPLF ORG

2
ASX suffers biggest fall since May as US increases tariffs on China

2018-07-11 theage.com.au
The Australian sharemarket has fallen for a second day in a row amid escalating trade tensions between the US and China.
RIO DB BLT RIO AGLNF MALRY MS.PRE MS.PRF MS.PRG IGO MS.PRA MIN OGFGY AGLNY RTPPF RTNTF MS WNARF WSA BHPBF IIDDY MS.PRI BHP RIO MS.PRK BBL BHP MALRF OGFGF BHPLF ORG

2
ASX suffers biggest fall since May as US increases tariffs on China

2018-07-11 smh.com.au
The Australian sharemarket has fallen for a second day in a row amid escalating trade tensions between the US and China.
RIO DB BLT RIO AGLNF MALRY MS.PRE MS.PRF MS.PRG IGO MS.PRA MIN OGFGY AGLNY RTPPF RTNTF MS WNARF WSA BHPBF IIDDY MS.PRI BHP RIO MS.PRK BBL BHP MALRF OGFGF BHPLF ORG

46
ASX breaks losing streak on mining and energy stock strength

2018-06-28 theage.com.au
The Australian sharemarket has broken a four day losing streak, rallying from an opening loss to close higher on Thursday
WOPEF RIO BLT RIO BHPBF WTCHF WPL OGFGY BCHEY WOPEY BEPTF BPT RTPPF BHP RIO RTNTF BBL BHP OGFGF BHPLF ORG

46
ASX breaks losing streak on mining and energy stock strength

2018-06-28 smh.com.au
The Australian sharemarket has broken a four day losing streak, rallying from an opening loss to close higher on Thursday
WOPEF RIO BLT RIO BHPBF WTCHF WPL OGFGY BCHEY WOPEY BEPTF BPT RTPPF BHP RIO RTNTF BBL BHP OGFGF BHPLF ORG

3
ASX backtracks from fresh decade high as banks slide

2018-06-25 theage.com.au
The ASX backtracked on Monday, giving up early gains to trade lower by the end of the session as losses for CBA and other banks weighed the index down and investors continued to fret about ongoing trade tensions between the US and China.
OISHF ASXFF WOPEF OISHY ASXFY OGFGF WPL OGFGY WOPEY ORG OSH

3
ASX backtracks from fresh decade high as banks slide

2018-06-25 smh.com.au
The ASX backtracked on Monday, giving up early gains to trade lower by the end of the session as losses for CBA and other banks weighed the index down and investors continued to fret about ongoing trade tensions between the US and China.
OISHF ASXFF WOPEF OISHY ASXFY OGFGF WPL OGFGY WOPEY ORG OSH

9
Rob McDonald to replace Ralph Norris as Contact Energy board chair

2018-06-14 nzherald.co.nz
Contact Energy chair Ralph Norris is stepping down from the board of New Zealand's largest electricity retailer having overseen a board refresh following the departure of majority owner Origin Energy.
CEN COENF ANZLY AIR CEN ANZFF OGFGF ANZFY COENY AIZ OGFGY ORG

2
Australia's top 100 companies hit 30% women on boards, now the rest?

2018-06-14 theage.com.au
Alleged misconduct by the management of financial corporations such as AMP is not the fault of women, says prominent business figure Kevin McCann, who believes that without strong gender diversity targets more women won't get appointed to boards.
MQBKY OGFGF MCQEF MQG OGFGY ORG

2
Australia's top 100 companies hit 30% women on boards, now the rest?

2018-06-14 smh.com.au
Alleged misconduct by the management of financial corporations such as AMP is not the fault of women, says prominent business figure Kevin McCann, who believes that without strong gender diversity targets more women won't get appointed to boards.
MQBKY OGFGF MCQEF MQG OGFGY ORG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 68618R200